Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1993 Mar;68(3):405–407. doi: 10.1136/adc.68.3.405

Unusual cyclosporin related neurological complications in recipients of liver transplants.

M R Cilio 1, O Danhaive 1, J F Gadisseux 1, J B Otte 1, E M Sokal 1
PMCID: PMC1793864  PMID: 8466245

Abstract

In a series of 256 recipients of paediatric liver transplants, from 1984 to 1990, four patients presented with sudden onset seizures not explained by conventional work-up. None had a family or personal history of seizures. Infectious causes were excluded. There were no glucose or electrolyte disturbances. Seizures were not induced by systemic or intracranial hypertension. One child out of four had transient white matter and cortex focal lesions on computed tomography of the brain. One to 10 days before seizures all four children presented with supratherapeutic concentrations of serum cyclosporin that were determined by a non-specific method that measured the parent compound plus its metabolites. The supratherapeutic concentrations were not found with the specific method measuring cyclosporin alone. It is concluded that these seizures may correspond to a toxic effect of cyclosporin, probably due to one or several metabolites, as suggested by the discrepancy between specific and non-specific methods of determination.

Full text

PDF
406

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams D. H., Ponsford S., Gunson B., Boon A., Honigsberger L., Williams A., Buckels J., Elias E., McMaster P. Neurological complications following liver transplantation. Lancet. 1987 Apr 25;1(8539):949–951. doi: 10.1016/s0140-6736(87)90294-7. [DOI] [PubMed] [Google Scholar]
  2. Cames B., Rahier J., Burtomboy G., de Ville de Goyet J., Reding R., Lamy M., Otte J. B., Sokal E. M. Acute adenovirus hepatitis in liver transplant recipients. J Pediatr. 1992 Jan;120(1):33–37. doi: 10.1016/s0022-3476(05)80593-1. [DOI] [PubMed] [Google Scholar]
  3. Cyclosporine-associated central nervous system toxicity. N Engl J Med. 1988 Mar 24;318(12):788–789. doi: 10.1056/NEJM198803243181217. [DOI] [PubMed] [Google Scholar]
  4. Deierhoi M. H., Kalayoglu M., Sollinger H. W., Belzer F. O. Cyclosporine neurotoxicity in liver transplant recipients: report of three cases. Transplant Proc. 1988 Feb;20(1):116–118. [PubMed] [Google Scholar]
  5. Durrant S., Chipping P. M., Palmer S., Gordon-Smith E. C. Cyclosporin A, methylprednisolone, and convulsions. Lancet. 1982 Oct 9;2(8302):829–830. doi: 10.1016/s0140-6736(82)92727-1. [DOI] [PubMed] [Google Scholar]
  6. Famiglio L., Racusen L., Fivush B., Solez K., Fisher R. Central nervous system toxicity of cyclosporine in a rat model. Transplantation. 1989 Aug;48(2):316–321. doi: 10.1097/00007890-198908000-00025. [DOI] [PubMed] [Google Scholar]
  7. Joss D. V., Barrett A. J., Kendra J. R., Lucas C. F., Desai S. Hypertension and convulsions in children receiving cyclosporin A. Lancet. 1982 Apr 17;1(8277):906–906. doi: 10.1016/s0140-6736(82)92171-7. [DOI] [PubMed] [Google Scholar]
  8. Kunzendorf U., Brockmöller J., Jochimsen F., Keller F., Walz G., Offermann G. Cyclosporin metabolites and central-nervous-system toxicity. Lancet. 1988 May 28;1(8596):1223–1223. doi: 10.1016/s0140-6736(88)92037-5. [DOI] [PubMed] [Google Scholar]
  9. McClung H. J., Sloan H. R., Powers P., Merola A. J., Murray R., Kerzner B., Pollack J. D. Early changes in the permeability of the blood-brain barrier produced by toxins associated with liver failure. Pediatr Res. 1990 Sep;28(3):227–231. doi: 10.1203/00006450-199009000-00014. [DOI] [PubMed] [Google Scholar]
  10. O'Sullivan D. P. Convulsions associated with cyclosporin A. Br Med J (Clin Res Ed) 1985 Mar 16;290(6471):858–858. doi: 10.1136/bmj.290.6471.858-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Otte J. B., Yandza T., de Ville de Goyet J., Tan K. C., Salizzoni M., de Hemptinne B. Pediatric liver transplantation: report on 52 patients with a 2-year survival of 86%. J Pediatr Surg. 1988 Mar;23(3):250–253. doi: 10.1016/s0022-3468(88)80733-4. [DOI] [PubMed] [Google Scholar]
  12. Otte J. B., de Ville de Goyet J., Sokal E., Alberti D., Moulin D., de Hemptinne B., Veyckemans F., van Obbergh L., Carlier M., Clapuyt P. Size reduction of the donor liver is a safe way to alleviate the shortage of size-matched organs in pediatric liver transplantation. Ann Surg. 1990 Feb;211(2):146–157. doi: 10.1097/00000658-199002000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Scheinman S. J., Reinitz E. R., Petro G., Schwartz R. A., Szmalc F. S. Cyclosporine central neurotoxicity following renal transplantation. Report of a case using magnetic resonance images. Transplantation. 1990 Jan;49(1):215–216. doi: 10.1097/00007890-199001000-00048. [DOI] [PubMed] [Google Scholar]
  14. Sokal E. M., Veyckemans F., de Ville de Goyet J., Moulin D., Van Hoorebeeck N., Alberti D., Buts J. P., Rahier J., Van Obbergh L., Clapuyt P. Liver transplantation in children less than 1 year of age. J Pediatr. 1990 Aug;117(2 Pt 1):205–210. doi: 10.1016/s0022-3476(05)80531-1. [DOI] [PubMed] [Google Scholar]
  15. Thompson C. B., June C. H., Sullivan K. M., Thomas E. D. Association between cyclosporin neurotoxicity and hypomagnesaemia. Lancet. 1984 Nov 17;2(8412):1116–1120. doi: 10.1016/s0140-6736(84)91556-3. [DOI] [PubMed] [Google Scholar]
  16. Truwit C. L., Denaro C. P., Lake J. R., DeMarco T. MR imaging of reversible cyclosporin A-induced neurotoxicity. AJNR Am J Neuroradiol. 1991 Jul-Aug;12(4):651–659. [PMC free article] [PubMed] [Google Scholar]
  17. Vogt D. P., Lederman R. J., Carey W. D., Broughan T. A. Neurologic complications of liver transplantation. Transplantation. 1988 Jun;45(6):1057–1061. doi: 10.1097/00007890-198806000-00011. [DOI] [PubMed] [Google Scholar]
  18. de Groen P. C., Aksamit A. J., Rakela J., Forbes G. S., Krom R. A. Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol. N Engl J Med. 1987 Oct 1;317(14):861–866. doi: 10.1056/NEJM198710013171404. [DOI] [PubMed] [Google Scholar]
  19. de Groen P. C. Cyclosporine, low-density lipoprotein, and cholesterol. Mayo Clin Proc. 1988 Oct;63(10):1012–1021. doi: 10.1016/s0025-6196(12)64916-7. [DOI] [PubMed] [Google Scholar]
  20. de Groen P. C., Wiesner R. H., Krom R. A. Advanced liver failure predisposes to cyclosporine-induced central nervous system symptoms after liver transplantation. Transplant Proc. 1989 Feb;21(1 Pt 2):2456–2456. [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES